tmi-358
Small moleculeexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2009 (NCT01093118)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tmi-358
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01093118 | Phase 2 | Sep 1, 2009 | J&S Studies Inc., Oregon Medical Research Center, Radiant Research, Talima Therapeutics, Inc. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| J&S Studies Inc. | For profit | 1 | 0 | 1 | 2009 |
| Oregon Medical Research Center | For profit | 1 | 0 | 1 | 2009 |
| Radiant Research | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Talima Therapeutics, Inc. | For profit | 1 | 1 | 1 | 2009 |
4 organizations
Page 1 / 1